A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia

UCI-17-114
NCT03416179
Cancer - Myeloid and Monocytic Leukemia
Susan O'Brien
Open
Treatment
Azacitidine, Cytarabine, Daunorubicin, Glasdegib, Placebo
III
Adult
National

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.